ClinicalTrials.gg
RecruitingNCT07823803Updated Sep 16, 2026

Improvised Endobag vs Direct Gallbladder Extraction in Laparoscopic Cholecystectomy

An interventional study of Endobag and placebo group in Cholecystectomy, Laparoscopic and Cholelithiasis, sponsored by Rawal Institute of Health Sciences Islamabad. Recruiting at 1 site in Pakistan. Open to participants aged 20 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-16.

Sponsored by Rawal Institute of Health Sciences Islamabad · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Aug 2026; still recruiting 2 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
20 Years to 70 Years
Sex
All
01

Study summary

Eligigble patients will be enrolled after obtaining informed consent. Basic information such as age, gender, body weight, smoking and alcohol history, number of gallstones, and gallbladder characteristics will be recorded.

During surgery, the method used to remove the gallbladder, the port used for extraction, and the duration of surgery will be documented. Any gallbladder perforation, leakage of bile, or spillage of gallstones during the procedure will also be recorded.

After surgery, patients will be monitored in the hospital for 24 hours. Their pain will be assessed before discharge. Patients will then be followed in the outpatient clinic for 10 days to assess wound healing and identify any wound infection or other complications.

The study aims to compare the safety and effectiveness of an improvised retrieval bag with removal of the gallbladder without a retrieval bag during laparoscopic surgery.

Read the detailed description

Eligible patients undergoing laparoscopic cholecystectomy will be enrolled after obtaining written informed consent. Baseline demographic and clinical characteristics, including age, gender, body mass index, smoking and alcohol history, hypertension, number of gallstones, and gallbladder wall thickness, will be recorded.

Patients will be randomly allocated to receive one of the predefined gallbladder extraction techniques. The port site used for gallbladder retrieval and total operative time will be documented. Intraoperative events, including gallbladder perforation, bile spillage, and stone spillage, will be recorded according to predefined operational definitions.

All procedures will be performed under general anesthesia by the same surgical team. Wound closure will be performed by the researcher using a standardized technique to minimize procedural variability and potential bias.

Following surgery, patients will be monitored in the postoperative ward for 24 hours. Postoperative pain will be assessed using a standardized pain score before discharge. Patients will subsequently be followed in the outpatient department for 10 days, during which the surgical wound will be assessed for infection and other relevant postoperative complications.

02

Conditions studied

  • Cholecystectomy, Laparoscopic
  • Cholelithiasis

Browse trials for

03

In context

Cholelithiasis

189 studies on the registry are indexed under Cholelithiasis; 42 are open to participants now.

This study's planned enrollment of 120 is above the median of 90 across 135 interventional studies indexed under Cholelithiasis.

Browse Cholelithiasis studies →

Lead sponsor

This is the only study on the registry with Rawal Institute of Health Sciences Islamabad as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Elective Laparoscopic Cholecystectomy

Exclusion criteria

Exclusion Criteria:

  • Patients having common bile duct stones or dilatation
  • Acute cholecystitis, gallbladder perforation, (on medical record).
  • Patients requiring conversion to open cholecystectomy,
  • Patients with skin diseases near wound site, diabetes (>6.5%), and \<10gm/dl
Terms in these criteria, in plain language(4)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

HbA1c

A blood test of average blood sugar over the past two to three months, given as a percentage or in mmol/mol. 6.5% (48 mmol/mol) or more is the usual threshold for diabetes, normally confirmed by a second test.

Hemoglobin (Hb)

The protein in red blood cells that carries oxygen. A low level is anaemia, which can cause tiredness and breathlessness. Measured in g/dL or g/L (9 g/dL is 90 g/L).

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
120 participants (estimated)

Study arms

  • Active comparator
    Group Endobag

    Device: Endobag

  • Placebo comparator
    Group Control

    Device: placebo group

Interventions

  • DeviceEndobag

    Gallbladder will be removed using Endobag

  • Deviceplacebo group

    Gallbladder will be removed without using Endobag during Laparoscopic Cholecystectomy

06

What researchers measure

Primary outcomes

  1. Surgical Time

    Time frame: This will be the time in minutes measured Peri-procedurally from skin incision to skin closure

  2. Visible perforation of the gallbladder developed during gallbladder removal

    Time frame: Perioperative/Periprocedural

  3. Visible spillage of bile from the gallbladder during gallbladder removal

    Time frame: Perioperative/Periprocedural (at the time of gallbladder removal)

  4. Visible spillage of gallstones from the gallbladder during gallbladder removal

    Time frame: Perioperative/Periprocedural

  5. Port site pain

    Time frame: It will be assessed using Visual Analog scale at 24 hours post procedure

07

Study locations

1 of 1 sites recruiting
  • Rawal Institute of Health Sciences
    Islamabad, Federal 44000, Pakistan
    Recruiting
    • Mirza · Contact
    • Mirza Inam Ul Haq, MBBS,MPH,MBA,PhD,PGD-HPE,MHPE · Contactfihs06.2023@gmail.com · +92-300-9527527
08

References and documents

Publications

  • Elangovan S, Naathan KVS, Sivamarieswaran R, Jose MR. Direct Gallbladder Extraction versus Endobag Extraction during Laparoscopic Cholecystectomy: A Prospective Observational Study. J Clin Diagn Res. 2025;19(8):PC12-PC5.

Individual participant data

Plan to share: No — Ethical committee doesnt allow data sharing

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 16, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07823803
Lead sponsor
Rawal Institute of Health Sciences Islamabad
Responsible party
Sadia Ali (Principal Investigator, Rawal Institute of Health Sciences Islamabad) — Principal investigator
First posted
Sep 16, 2026
Start date
Aug 30, 2026
Primary completion
Nov 30, 2026 (estimated)
Completion
Nov 30, 2026 (estimated)
Last update
Sep 16, 2026

Study contacts

Sadia Principal Investigator, MBBS
Contact
sadiaali603@gmail.com
+92-318-5190442

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion